RPRX Latest Headlines

Royalty Pharma Earnings Call Balances Strength And Risk

at www.tipranks.com (Fri, 13-Feb 7:24 PM)

Analysts Conflicted on These Healthcare Names: Dexcom (DXCM), Vertex Pharmaceuticals (VRTX) and Royalty Pharma (RPRX)

at www.tipranks.com (Fri, 13-Feb 8:30 AM)

Bank of America Securities Keeps Their Buy Rating on Royalty Pharma (RPRX)

at www.tipranks.com (Thu, 12-Feb 7:59 AM)

Royalty Pharma targets 3%–8% royalty receipts growth in 2026 while advancing $4.7B in transactions

at seekingalpha.com (Wed, 11-Feb 4:45 PM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY), Edwards Lifesciences (EW) and Royalty Pharma (RPRX)

at www.tipranks.com (Wed, 11-Feb 7:11 AM)

Royalty Pharma reports Q4 results

at seekingalpha.com (Wed, 11-Feb 7:10 AM)

Here are the major earnings before the open Wednesday

at seekingalpha.com (Tue, 10-Feb 6:00 PM)

Royalty Pharma Q4 2025 Earnings Preview

at seekingalpha.com (Tue, 10-Feb 9:54 AM)